Circulating proteins as predictors of cardiovascular mortality in end-stage renal diseaseTobias Feldreich, Johan Ärnlöv, Abdul Rashid Qureshi et al.|Journal of Nephrology|2018Cited by 65
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysisPeter Taylor, Jan Dutz, Kimberly S. Collins et al.|The Lancet Diabetes & Endocrinology|2023Cited by 58
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium studyPatrick B. Mark, Bénédicte Stengel, Juan Jesús Carrero et al.|European Heart Journal|2023Cited by 32